What Is GLI1 and Why Is It Important?

GLI1 (GLI Family Zinc Finger 1) is a transcription factor and the primary transcriptional activator of the Hedgehog (Hh) signaling pathway. It belongs to the Krüppel-like zinc finger protein family and binds to specific DNA sequences to activate target gene expression. GLI1 is considered a direct transcriptional target and positive feedback amplifier of the Hh pathway, making it a reliable marker of active Hh signaling in cells.

GLI1 plays critical roles during embryonic development, regulating tissue patterning, cell proliferation, and differentiation. In adult tissues, dysregulated GLI1 activity has been associated with multiple cancers, including basal cell carcinoma, medulloblastoma, pancreatic cancer, and glioblastoma, making it a key target of interest in oncology research.

Product Overview and Specifications

Aladdin Scientific's Recombinant Human GLI1 Protein (SKU: rp366410) is produced for use in biochemical and cell-based research applications. The recombinant protein is derived from the human GLI1 gene sequence and is intended to support studies requiring exogenous GLI1 protein, including pathway reconstitution assays, protein-protein interaction studies, and antibody validation.

Researchers should consult the product datasheet for confirmed details on expression host system, tag information, molecular weight, purity grade, and formulation buffer, as these specifications directly affect experimental design and compatibility. Please contact Aladdin Scientific technical support or refer to the certificate of analysis (CoA) supplied with each lot for lot-specific quality data.

Storage, Handling, and Reconstitution Guidelines

Proper handling of Recombinant Human GLI1 Protein is essential to preserve biological activity and ensure reproducible results. General best-practice guidelines for recombinant proteins of this type include:

• Storage: Store at -80°C upon receipt for long-term preservation. Short-term storage at -20°C may be acceptable; consult the product datasheet for confirmed conditions.
• Freeze-thaw cycles: Minimize the number of freeze-thaw cycles. Aliquot the protein into single-use volumes upon first thaw to prevent repeated freeze-thaw degradation.
• Reconstitution: If supplied in lyophilized form, reconstitute with the recommended volume of sterile, nuclease-free water or the buffer specified in the datasheet. Allow the vial to equilibrate to room temperature before opening. Mix gently by pipetting; avoid vigorous vortexing.
• Protein stability: Adding a carrier protein such as 0.1% BSA to the reconstitution buffer may enhance stability during storage and dilution. Consult the datasheet for specific recommendations.

Always centrifuge the vial briefly before opening to consolidate lyophilized material. Work on ice when handling thawed protein to minimize activity loss.

Experimental Applications of Recombinant Human GLI1 Protein

Recombinant Human GLI1 Protein supports a range of research applications in laboratories studying the Hedgehog pathway and related biology:

• Protein-protein interaction assays: GLI1 interacts with multiple co-regulators and inhibitors within the Hh pathway. Recombinant GLI1 can be used in pull-down assays, co-immunoprecipitation, and surface plasmon resonance (SPR) experiments to map interaction interfaces.
• Antibody validation and ELISA development: Recombinant GLI1 serves as a positive control or coating antigen for validating anti-GLI1 antibodies and developing sandwich ELISA systems.
• Biochemical activity assays: In vitro DNA-binding assays such as electrophoretic mobility shift assays (EMSA) can be performed using recombinant GLI1 to characterize its DNA recognition and binding properties.
• Structural studies: Purified recombinant GLI1 or its domains can support crystallography or cryo-EM studies aimed at resolving GLI1 structure for drug discovery purposes.
• Drug screening: As a validated oncogenic driver, GLI1 recombinant protein can be incorporated into high-throughput screening assays to identify small-molecule inhibitors of GLI1-DNA binding or GLI1-protein interactions.

Troubleshooting Common Issues

Researchers working with Recombinant Human GLI1 Protein may encounter the following challenges. The guidance below reflects general best practices for recombinant transcription factor proteins:

• Low or no activity after reconstitution: Ensure the protein has been reconstituted in the correct buffer at the recommended concentration. Avoid vortexing. Confirm the protein has not undergone multiple freeze-thaw cycles. Check that storage temperature was maintained.
• Protein aggregation: Aggregation can occur at high concentrations or after improper freeze-thaw. Centrifuge the reconstituted protein at 10,000–14,000 × g for 5 minutes at 4°C before use to remove aggregates. Consider adding a carrier protein (e.g., 0.1% BSA).
• Inconsistent results between lots: Always run a positive control using a validated lot. Review the CoA for each lot for purity and activity data. Contact Aladdin Scientific technical support if significant lot-to-lot variability is observed.
• Non-specific binding in ELISA or pull-down: Optimize blocking conditions and antibody/protein concentrations. Confirm that the tag on the recombinant protein does not interfere with the detection antibody epitope.

For application-specific troubleshooting beyond the scope of this article, please contact Aladdin Scientific technical support with your lot number, application details, and experimental conditions.